Cargando…
Sitting less and moving more for improved metabolic and brain health in type 2 diabetes: ‘OPTIMISE your health’ trial protocol
BACKGROUND: Clinical practice guidelines recommend that adults with type 2 diabetes (T2D) sit less and move more throughout the day. The 18-month OPTIMISE Your Health Clinical Trial was developed to support desk-based workers with T2D achieve these recommendations. The two-arm protocol consists of a...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086419/ https://www.ncbi.nlm.nih.gov/pubmed/35538430 http://dx.doi.org/10.1186/s12889-022-13123-x |
_version_ | 1784703995888009216 |
---|---|
author | Brakenridge, Christian J. Gardiner, Paul A. Grigg, Ruth V. Winkler, Elisabeth A. H. Fjeldsoe, Brianna S. Schaumberg, Mia A. Owen, Neville Eakin, Elizabeth G. Biddle, Stuart J. H. Moodie, Marjory Daly, Robin M. Green, Daniel J. Cohen, Neale Gray, Len Comans, Tracy Buman, Matthew P. Goode, Ana D. Nguyen, Phuong Gao, Lan Healy, Genevieve N. Dunstan, David W. |
author_facet | Brakenridge, Christian J. Gardiner, Paul A. Grigg, Ruth V. Winkler, Elisabeth A. H. Fjeldsoe, Brianna S. Schaumberg, Mia A. Owen, Neville Eakin, Elizabeth G. Biddle, Stuart J. H. Moodie, Marjory Daly, Robin M. Green, Daniel J. Cohen, Neale Gray, Len Comans, Tracy Buman, Matthew P. Goode, Ana D. Nguyen, Phuong Gao, Lan Healy, Genevieve N. Dunstan, David W. |
author_sort | Brakenridge, Christian J. |
collection | PubMed |
description | BACKGROUND: Clinical practice guidelines recommend that adults with type 2 diabetes (T2D) sit less and move more throughout the day. The 18-month OPTIMISE Your Health Clinical Trial was developed to support desk-based workers with T2D achieve these recommendations. The two-arm protocol consists of an intervention and control arms. The intervention arm receives 6 months health coaching, a sit-stand desktop workstation and an activity tracker, followed by 6 months of text message support, then 6 months maintenance. The control arm receives a delayed modified intervention after 12 months of usual care. This paper describes the methods of a randomised controlled trial (RCT) evaluating the effectiveness and cost-effectiveness of the intervention, compared to a delayed intervention control. METHODS: This is a two-arm RCT being conducted in Melbourne, Australia. Desk-based workers (≥0.8 full-time equivalent) aged 35–65 years, ambulatory, and with T2D and managed glycaemic control (6.5–10.0% HbA1c), are randomised to the multicomponent intervention (target n = 125) or delayed-intervention control (target n = 125) conditions. All intervention participants receive 6 months of tailored health coaching assisting them to “sit less” and “move more” at work and throughout the day, supported by a sit-stand desktop workstation and an activity tracker (Fitbit). Participants receive text message-based extended care for a further 6-months (6–12 months) followed by 6-months of non-contact (12–18 months: maintenance). Delayed intervention occurs at 12–18 months for the control arm. Assessments are undertaken at baseline, 3, 6, 12, 15 and 18-months. Primary outcomes are activPAL-measured sitting time (h/16 h day), glycosylated haemoglobin (HbA1c; %, mmol/mol) and, cognitive function measures (visual learning and new memory; Paired Associates Learning Total Errors [adjusted]). Secondary, exploratory, and process outcomes will also be collected throughout the trial. DISCUSSION: The OPTIMISE Your Health trial will provide unique insights into the benefits of an intervention aimed at sitting less and moving more in desk-bound office workers with T2D, with outcomes relevant to glycaemic control, and to cardiometabolic and brain health. Findings will contribute new insights to add to the evidence base on initiating and maintaining behaviour change with clinical populations and inform practice in diabetes management. TRIAL REGISTRATION: ANZCTRN12618001159246. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-022-13123-x. |
format | Online Article Text |
id | pubmed-9086419 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-90864192022-05-10 Sitting less and moving more for improved metabolic and brain health in type 2 diabetes: ‘OPTIMISE your health’ trial protocol Brakenridge, Christian J. Gardiner, Paul A. Grigg, Ruth V. Winkler, Elisabeth A. H. Fjeldsoe, Brianna S. Schaumberg, Mia A. Owen, Neville Eakin, Elizabeth G. Biddle, Stuart J. H. Moodie, Marjory Daly, Robin M. Green, Daniel J. Cohen, Neale Gray, Len Comans, Tracy Buman, Matthew P. Goode, Ana D. Nguyen, Phuong Gao, Lan Healy, Genevieve N. Dunstan, David W. BMC Public Health Study Protocol BACKGROUND: Clinical practice guidelines recommend that adults with type 2 diabetes (T2D) sit less and move more throughout the day. The 18-month OPTIMISE Your Health Clinical Trial was developed to support desk-based workers with T2D achieve these recommendations. The two-arm protocol consists of an intervention and control arms. The intervention arm receives 6 months health coaching, a sit-stand desktop workstation and an activity tracker, followed by 6 months of text message support, then 6 months maintenance. The control arm receives a delayed modified intervention after 12 months of usual care. This paper describes the methods of a randomised controlled trial (RCT) evaluating the effectiveness and cost-effectiveness of the intervention, compared to a delayed intervention control. METHODS: This is a two-arm RCT being conducted in Melbourne, Australia. Desk-based workers (≥0.8 full-time equivalent) aged 35–65 years, ambulatory, and with T2D and managed glycaemic control (6.5–10.0% HbA1c), are randomised to the multicomponent intervention (target n = 125) or delayed-intervention control (target n = 125) conditions. All intervention participants receive 6 months of tailored health coaching assisting them to “sit less” and “move more” at work and throughout the day, supported by a sit-stand desktop workstation and an activity tracker (Fitbit). Participants receive text message-based extended care for a further 6-months (6–12 months) followed by 6-months of non-contact (12–18 months: maintenance). Delayed intervention occurs at 12–18 months for the control arm. Assessments are undertaken at baseline, 3, 6, 12, 15 and 18-months. Primary outcomes are activPAL-measured sitting time (h/16 h day), glycosylated haemoglobin (HbA1c; %, mmol/mol) and, cognitive function measures (visual learning and new memory; Paired Associates Learning Total Errors [adjusted]). Secondary, exploratory, and process outcomes will also be collected throughout the trial. DISCUSSION: The OPTIMISE Your Health trial will provide unique insights into the benefits of an intervention aimed at sitting less and moving more in desk-bound office workers with T2D, with outcomes relevant to glycaemic control, and to cardiometabolic and brain health. Findings will contribute new insights to add to the evidence base on initiating and maintaining behaviour change with clinical populations and inform practice in diabetes management. TRIAL REGISTRATION: ANZCTRN12618001159246. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-022-13123-x. BioMed Central 2022-05-10 /pmc/articles/PMC9086419/ /pubmed/35538430 http://dx.doi.org/10.1186/s12889-022-13123-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Study Protocol Brakenridge, Christian J. Gardiner, Paul A. Grigg, Ruth V. Winkler, Elisabeth A. H. Fjeldsoe, Brianna S. Schaumberg, Mia A. Owen, Neville Eakin, Elizabeth G. Biddle, Stuart J. H. Moodie, Marjory Daly, Robin M. Green, Daniel J. Cohen, Neale Gray, Len Comans, Tracy Buman, Matthew P. Goode, Ana D. Nguyen, Phuong Gao, Lan Healy, Genevieve N. Dunstan, David W. Sitting less and moving more for improved metabolic and brain health in type 2 diabetes: ‘OPTIMISE your health’ trial protocol |
title | Sitting less and moving more for improved metabolic and brain health in type 2 diabetes: ‘OPTIMISE your health’ trial protocol |
title_full | Sitting less and moving more for improved metabolic and brain health in type 2 diabetes: ‘OPTIMISE your health’ trial protocol |
title_fullStr | Sitting less and moving more for improved metabolic and brain health in type 2 diabetes: ‘OPTIMISE your health’ trial protocol |
title_full_unstemmed | Sitting less and moving more for improved metabolic and brain health in type 2 diabetes: ‘OPTIMISE your health’ trial protocol |
title_short | Sitting less and moving more for improved metabolic and brain health in type 2 diabetes: ‘OPTIMISE your health’ trial protocol |
title_sort | sitting less and moving more for improved metabolic and brain health in type 2 diabetes: ‘optimise your health’ trial protocol |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086419/ https://www.ncbi.nlm.nih.gov/pubmed/35538430 http://dx.doi.org/10.1186/s12889-022-13123-x |
work_keys_str_mv | AT brakenridgechristianj sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT gardinerpaula sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT griggruthv sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT winklerelisabethah sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT fjeldsoebriannas sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT schaumbergmiaa sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT owenneville sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT eakinelizabethg sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT biddlestuartjh sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT moodiemarjory sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT dalyrobinm sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT greendanielj sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT cohenneale sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT graylen sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT comanstracy sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT bumanmatthewp sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT goodeanad sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT nguyenphuong sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT gaolan sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT healygenevieven sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol AT dunstandavidw sittinglessandmovingmoreforimprovedmetabolicandbrainhealthintype2diabetesoptimiseyourhealthtrialprotocol |